Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
Sports
History
TV & Film
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts211/v4/bf/7b/f1/bf7bf14c-292d-732f-d4d8-6a5c00a21127/mza_5387757582390035217.jpg/600x600bb.jpg
Power to the Patients
Brandon Li
41 episodes
1 day ago
Power to the Patients is a LinkedIn Live and podcast series hosted by Power where clinical research leaders across sponsors, sites, CROs, and patient advocacy groups discuss patient centricity in clinical trials. We explore the bottlenecks in today's systems, challenge the status quo and talk about future opportunities for innovation. Looking for a clinical trial? Visit us at www.withpower.com
Show more...
Life Sciences
Science
RSS
All content for Power to the Patients is the property of Brandon Li and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Power to the Patients is a LinkedIn Live and podcast series hosted by Power where clinical research leaders across sponsors, sites, CROs, and patient advocacy groups discuss patient centricity in clinical trials. We explore the bottlenecks in today's systems, challenge the status quo and talk about future opportunities for innovation. Looking for a clinical trial? Visit us at www.withpower.com
Show more...
Life Sciences
Science
https://content.fameapp.so/uploads/4j14kx7q/6f0481e0-84e1-11f0-934d-95c28aba2c98/6f047de0-84e1-11f0-8138-3b7aa54b8de9.png
Gerard Sanacora, Professor at Yale, on glutamate, GABA, and the next era of depression treatment
Power to the Patients
53 minutes
4 months ago
Gerard Sanacora, Professor at Yale, on glutamate, GABA, and the next era of depression treatment
Brandon Li talks with Dr. Gerard Sanacora, Professor of Psychiatry at Yale, about his journey from molecular physiology to pioneering research on GABA, glutamate, and rapid-acting antidepressants. Gerard shares how a surprising finding in patients undergoing ECT redirected his research toward depression—and eventually to ketamine. Their conversation explores the science of neuroplasticity, the complexities behind ketamine’s mechanism of action, and how interventional psychiatry and digital tools may shape the future of mental health care.
Power to the Patients
Power to the Patients is a LinkedIn Live and podcast series hosted by Power where clinical research leaders across sponsors, sites, CROs, and patient advocacy groups discuss patient centricity in clinical trials. We explore the bottlenecks in today's systems, challenge the status quo and talk about future opportunities for innovation. Looking for a clinical trial? Visit us at www.withpower.com